1-苄基-4-(甲氧基乙烯基)哌啶 | 137996-00-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 中文名称: 1-苄基-4-(甲氧基乙烯基)哌啶
• 英文名称: 1-benzyl-4-(methoxyethenyl)piperidine
• 英文别名: 1-Benzyl-4(2'-methoxyethenyl)piperidine；1-benzyl-4-(2-methoxyethenyl)piperidine
• CAS: 137996-00-0
• 化学式: C₁₅H₂₁NO
• 分子量: 231.338
• InChiKey: GHUOIKGCIDFVBU-UHFFFAOYSA-N

物化性质

• 沸点：
  314.0±35.0 °C(Predicted)
• 密度：
  1.060±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.47
• 拓扑面积：
  12.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-苄基-4-(甲氧基乙烯基)哌啶 在 盐酸 、 magnesium 作用下， 以 四氢呋喃 为溶剂， 反应 32.0h， 生成 2-(1-Benzyl-piperidin-4-yl)-1-[4-(tert-butyl-dimethyl-silanyloxymethyl)-phenyl]-ethanol
  参考文献：
  名称：

  Novel piperidine .sigma. receptor ligands as potential antipsychotic drugs

  摘要：

  Sigma receptor ligands represent a new class of potential antipsychotic drugs. This paper presents the structure-activity relationships leading to novel disubstituted piperidine sigma ligands, which have little or no affinity for dopamine D2 receptors. Selectivity for sigma sites over dopamine D2 or serotonin 5-HT2 receptors appears to be governed by the chemical nature of the piperidine nitrogen substituent, its distance from the basic nitrogen, and its orientation relative to the other piperidine substituent. Several of these compounds have good oral potency in some animal models used to evaluate potential antipsychotic drugs. The N-cyclopropylmethyl ketones and ethers (e.g. 6i (DuP 734), 6q, 18a, and 18n) have the best in vivo potency. Compounds 6i (DuP 734) and 6q did not cause catalepsy in the rat, even at very high doses. On the basis of the pharmacology profiles of these sigma ligands, we propose these compounds may be effective antipsychotic drugs, which do not induce extrapyramidal side effects or tardive dyskinesia.

  DOI：

  10.1021/jm00101a012
• 作为产物：
  描述：

  1-苄基-4-哌啶甲酸乙酯 在 lithium aluminium tetrahydride 、 草酰氯 、 二甲基亚砜 、 三乙胺 、 lithium diisopropyl amide 作用下， 以 四氢呋喃 为溶剂， 反应 45.83h， 生成 1-苄基-4-(甲氧基乙烯基)哌啶
  参考文献：
  名称：

  Novel piperidine .sigma. receptor ligands as potential antipsychotic drugs

  摘要：

  Sigma receptor ligands represent a new class of potential antipsychotic drugs. This paper presents the structure-activity relationships leading to novel disubstituted piperidine sigma ligands, which have little or no affinity for dopamine D2 receptors. Selectivity for sigma sites over dopamine D2 or serotonin 5-HT2 receptors appears to be governed by the chemical nature of the piperidine nitrogen substituent, its distance from the basic nitrogen, and its orientation relative to the other piperidine substituent. Several of these compounds have good oral potency in some animal models used to evaluate potential antipsychotic drugs. The N-cyclopropylmethyl ketones and ethers (e.g. 6i (DuP 734), 6q, 18a, and 18n) have the best in vivo potency. Compounds 6i (DuP 734) and 6q did not cause catalepsy in the rat, even at very high doses. On the basis of the pharmacology profiles of these sigma ligands, we propose these compounds may be effective antipsychotic drugs, which do not induce extrapyramidal side effects or tardive dyskinesia.

  DOI：

  10.1021/jm00101a012

文献信息

• N-aralkyl piperidine derivatives as psychotropic drugs
  申请人：Du Pont Merck Pharmaceutical Company

  公开号：US05116846A1

  公开（公告）日：1992-05-26

  There are provided N-aralkyl piperidine derivatives which are selective sigma receptor antagonists. These compounds and pharmaceutical compositions containing them are useful for treating physiological or drug induced psychosis or dyskinesia in a mammal.

  提供了选择性sigma受体拮抗剂的N-芳基烷基哌嗪衍生物。这些化合物和含有它们的药物组合物可用于治疗哺乳动物中的生理或药物诱导的精神病或运动障碍。